(Q41201032)

English

Molecular classification of diffuse cerebral WHO grade II/III gliomas using genome- and transcriptome-wide profiling improves stratification of prognostically distinct patient groups

scientific article published on 18 March 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

28 September 2017

Molecular classification of diffuse cerebral WHO grade II/III gliomas using genome- and transcriptome-wide profiling improves stratification of prognostically distinct patient groups (English)

1 reference

Europe PubMed Central

28 September 2017

World Health Organization

0 references

0 references

1 reference

based on heuristic

inferred from title

Bernhard Radlwimmer

27

1 reference

Europe PubMed Central

28 September 2017

1

object named as

Michael Weller

1 reference

Europe PubMed Central

28 September 2017

24

object named as

Wolfgang Wick

1 reference

Europe PubMed Central

28 September 2017

Andreas von Deimling

30

object named as

Andreas von Deimling

1 reference

Europe PubMed Central

28 September 2017

Guido Reifenberger

32

object named as

Guido Reifenberger

1 reference

Europe PubMed Central

28 September 2017

7

object named as

Jörg Felsberg

1 reference

Europe PubMed Central

28 September 2017

Henry Löffler-Wirth

9

object named as

Henry Löffler-Wirth

1 reference

Europe PubMed Central

28 September 2017

Simon Matthias May

17

object named as

Matthias Simon

1 reference

Europe PubMed Central

28 September 2017

Manfred Westphal

15

object named as

Manfred Westphal

1 reference

Europe PubMed Central

28 September 2017

Johannes Schramm

14

object named as

Johannes Schramm

1 reference

Europe PubMed Central

28 September 2017

Gabriele Schackert

16

object named as

Gabriele Schackert

1 reference

Europe PubMed Central

28 September 2017

Michael S Sabel

21

object named as

Michael Sabel

1 reference

Europe PubMed Central

28 September 2017

Joachim Steinbach

11

object named as

Joachim P Steinbach

1 reference

Europe PubMed Central

28 September 2017

22

object named as

Dietmar Krex

1 reference

Europe PubMed Central

28 September 2017

Dorothee Gramatzki

13

object named as

Dorothee Gramatzki

1 reference

Europe PubMed Central

28 September 2017

Bettina Hentschel

5

object named as

Bettina Hentschel

1 reference

Europe PubMed Central

28 September 2017

Ruthild G Weber

2

object named as

Ruthild G Weber

1 reference

Europe PubMed Central

28 September 2017

Edith Willscher

3

object named as

Edith Willscher

1 reference

Europe PubMed Central

28 September 2017

4

object named as

Vera Riehmer

1 reference

Europe PubMed Central

28 September 2017

Kerstin Kaulich

10

object named as

Kerstin Kaulich

1 reference

Europe PubMed Central

28 September 2017

31

object named as

Hans Binder

1 reference

Europe PubMed Central

28 September 2017

Jörg-Christian Tonn

23

object named as

Jörg C Tonn

1 reference

Europe PubMed Central

28 September 2017

author name string

Markus Kreuz

6

1 reference

Europe PubMed Central

28 September 2017

Ulrike Beyer

8

1 reference

Europe PubMed Central

28 September 2017

Christian Hartmann

12

1 reference

Europe PubMed Central

28 September 2017

Tobias Martens

18

1 reference

Europe PubMed Central

28 September 2017

Jan Boström

19

1 reference

Europe PubMed Central

28 September 2017

Christian Hagel

20

1 reference

Europe PubMed Central

28 September 2017

Susan Noell

25

1 reference

Europe PubMed Central

28 September 2017

Uwe Schlegel

26

1 reference

Europe PubMed Central

28 September 2017

Torsten Pietsch

28

1 reference

Europe PubMed Central

28 September 2017

Markus Loeffler

29

1 reference

Europe PubMed Central

28 September 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

18 March 2015

1 reference

Europe PubMed Central

28 September 2017

Acta Neuropathologica

1 reference

Europe PubMed Central

28 September 2017

129

1 reference

Europe PubMed Central

28 September 2017

5

1 reference

Europe PubMed Central

28 September 2017

679-693

1 reference

Europe PubMed Central

28 September 2017

https://scigraph.springernature.com/pub.10.1007/s00401-015-1409-0

0 references

Update on molecular findings, management and outcome in low-grade gliomas

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1409-0

21 January 2018

Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402.

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1409-0

21 January 2018

Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402.

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1409-0

21 January 2018

Benefit from procarbazine, lomustine, and vincristine in oligodendroglial tumors is associated with mutation of IDH.

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1409-0

21 January 2018

The proneural molecular signature is enriched in oligodendrogliomas and predicts improved survival among diffuse gliomas

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1409-0

21 January 2018

alpha-Internexin expression identifies 1p19q codeleted gliomas.

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1409-0

21 January 2018

Anaplastic oligodendrogliomas with 1p19q codeletion have a proneural gene expression profile

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1409-0

21 January 2018

Prognostic significance of molecular markers and extent of resection in primary glioblastoma patients

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1409-0

21 January 2018

Rapid and sensitive assessment of the IDH1 and IDH2 mutation status in cerebral gliomas based on DNA pyrosequencing

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1409-0

21 January 2018

Clinical utility of fluorescence in situ hybridization (FISH) in morphologically ambiguous gliomas with hybrid oligodendroglial/astrocytic features.

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1409-0

21 January 2018

Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1409-0

21 January 2018

Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas.

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1409-0

21 January 2018

Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomas

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1409-0

21 January 2018

Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1409-0

21 January 2018

Mutations in IDH1, IDH2, and in the TERT promoter define clinically distinct subgroups of adult malignant gliomas

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1409-0

21 January 2018

The genetic landscape of anaplastic astrocytoma

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1409-0

21 January 2018

Distribution of TERT promoter mutations in pediatric and adult tumors of the nervous system.

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1409-0

21 January 2018

Frequent ATRX mutations and loss of expression in adult diffuse astrocytic tumors carrying IDH1/IDH2 and TP53 mutations

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1409-0

21 January 2018

International Society Of Neuropathology--Haarlem consensus guidelines for nervous system tumor classification and grading

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1409-0

21 January 2018

Selective expression of a subset of neuronal genes in oligodendroglioma with chromosome 1p loss.

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1409-0

21 January 2018

The definition of primary and secondary glioblastoma

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1409-0

21 January 2018

Molecular characterization of long-term survivors of glioblastoma using genome- and transcriptome-wide profiling.

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1409-0

21 January 2018

Farewell to oligoastrocytoma: in situ molecular genetics favor classification as either oligodendroglioma or astrocytoma

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1409-0

21 January 2018

Gene expression in oligodendroglial tumors.

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1409-0

21 January 2018

Identification of novel oligodendroglioma-associated candidate tumor suppressor genes in 1p36 and 19q13 using microarray-based expression profiling.

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1409-0

21 January 2018

Interobserver variation of the histopathological diagnosis in clinical trials on glioma: a clinician's perspective

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1409-0

21 January 2018

Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC brain tumor group study 26951.

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1409-0

21 January 2018

Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: a randomized European Organisation for Research and Treatment [...]

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1409-0

21 January 2018

Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1409-0

21 January 2018

Molecular predictors of progression-free and overall survival in patients with newly diagnosed glioblastoma: a prospective translational study of the German Glioma Network

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1409-0

21 January 2018

Molecular neuro-oncology in clinical practice: a new horizon

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1409-0

21 January 2018

NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1409-0

21 January 2018

Prognostic or predictive value of MGMT promoter methylation in gliomas depends on IDH1 mutation

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1409-0

21 January 2018

ATRX loss refines the classification of anaplastic gliomas and identifies a subgroup of IDH mutant astrocytic tumors with better prognosis

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1409-0

21 January 2018

Assessing CpG island methylator phenotype, 1p/19q codeletion, and MGMT promoter methylation from epigenome-wide data in the biomarker cohort of the NOA-04 trial

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1409-0

21 January 2018

Integrated DNA methylation and copy-number profiling identify three clinically and biologically relevant groups of anaplastic glioma.

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1409-0

21 January 2018

Expression cartography of human tissues using self organizing maps

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1409-0

21 January 2018

Mining SOM expression portraits: feature selection and integrating concepts of molecular function

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1409-0

21 January 2018

Detection of chromosomal imbalances in retinoblastoma by matrix-based comparative genomic hybridization

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1409-0

21 January 2018

Identifiers

10.1007/S00401-015-1409-0

1 reference

Europe PubMed Central

28 September 2017

release_4q7osaxpnvfrxke5f4gksievdy

1 reference

https://api.fatcat.wiki/v0/release/4q7osaxpnvfrxke5f4gksievdy

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

28 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41201032&oldid=2094241739"